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Abstract
Background: We evaluate the effectiveness of a physical activity promotion programme carried out by general practitioners
with inactive patients in routine care.
Methods and Findings: Pragmatic, cluster randomised clinical trial conducted in eleven public primary care centres in
Spain. Fifty-six general practitioners (GPs) were randomly assigned to intervention (29) or standard care (27) groups. They
assessed the physical activity level of a systematic sample of patients in routine practice and recruited 4317 individuals
(2248 intervention and 2069 control) who did not meet minimum physical activity recommendations. Intervention GPs
provided advice to all patients and a physical activity prescription to the subgroup attending an additional appointment
(30%). A third of these prescriptions were opportunistically repeated. Control GPs provided standard care. Primary outcome
measure was the change in self-reported physical activity from baseline to six, 12 and 24 months. Secondary outcomes
included cardiorespiratory fitness and health-related quality of life. A total of 3691 patients (85%) were included in the
longitudinal analysis and overall trends over the whole 24 month follow-up were significantly better in the intervention
group (p,0.01). The greatest differences with the control group were observed at six months (adjusted difference 1.7
MET*hr/wk [95% CI, 0.8 to 2.6], 25 min/wk [95% CI, 11.3 to 38.4], and a 5.3% higher percentage of patients meeting
minimum recommendations [95% CI: 2.1% to 8.8%] NNT=19). These differences were not statistically significant at 12 and
24 months. No differences were found in secondary outcomes. A significant difference was maintained until 24 months in
the proportion of patients achieving minimum recommendation in the subgroup that received a repeat prescription
(adjusted difference 10.2%, 95% CI 1.5% to 19.4%).
Conclusions: General practitioners are effective at increasing the level of physical activity among their inactive patients
during the initial six-months of an intervention but this effect wears off at 12 and 24 months. Only in the subgroup of
patients receiving repeat prescriptions of physical activity is the effect maintained in long-term.
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Introduction
The benefits of physical activity for health promotion and
prevention of most common chronic diseases are so great that it is
probably the most important healthy habit to maintain and the
most useful self help treatment available. Regular physical activity
improves quality of life, prevents cardiovascular and respiratory
disease, obesity, type 2 diabetes, hypertension, osteoporosis, some
cancers, and depression, improves the symptoms of anxiety and
other illnesses, and decreases all-cause mortality [1–2]. Accord-
ingly, public health authorities and scientific organizations
recommend at least 30 minutes of moderately intense physical
activity most days of the week [1,3]. Despite this, inactive and
sedentary lifestyles remain a problem for the majority of the
population in industrialized countries, overall levels of physical
activity continue to be low or are even declining [1,4,5], and
physical activity promotion represents a public health priority.
General practitioners can play a key role in population health
throughout physical activity promotion. However, evidence about
these interventions in routine practice has so far been inconclusive,
especially regarding their long-term effectiveness [6–7]. This
uncertainty generates disagreement between scientific organiza-
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should do. While some organisations recommended that primary
care practitioners should take the opportunity, whenever possible,
to identify inactive adults and advise them [8], other conclude that
the evidence is insufficient to recommend for or against
behavioural counselling in primary care [9]. The purpose of our
study is to address such a relevant question: which is the specific
effect general practitioners have when they try to promote physical
activity among their inactive patients.
We recently reported general practitioners to be effective at
promoting physical activity for a six-month period [10]. However,
maintenance of an active lifestyle is essential to achieve health
benefitsandevidenceforthelong-termeffectivenessofinterventions
is urgentlyrequired [6,7]. Therearefewclinical trials intheprimary
care setting with positive long-term results beyond 12 months [6,7].
B. A. Lawton et al found that the ‘‘green prescription’’ intervention
can increase physical activity of inactive women over two years.
This intervention included multiple sessions with a primary care
nurse and a community exercise specialist over a nine-month
period. The effect of the intervention on physical activity levels
increased for as long as 12 months, with a further decline at the end
of two years. The authors acknowledged the limited generalizability
of their results due to the biased selection of participants and
because the intervention was not part of routine care [11]. The
Activity Counseling Trial compared three different intensity
interventions over two years and found no effects on physical
activity. The two more intensive interventions produced a greater
improvement incardiorespiratory fitnessinthe subgroupofwomen.
However, this study had no control group and therefore it did not
directly address the central question considered in the present study
that remains unanswered, namely, whether family physicians’
interventions in routine conditions increase their patients’ physical
activity in the long term [12,13].
In the reported preliminary results of this clinical trial, the
PEPAF (‘‘Experimental Programme for Physical Activity Promo-
tion’’) programme implemented by general practitioners in routine
practice was shown to be effective at six months follow-up [10]. As
the PEPAF programme is a brief intervention based on physicians’
behavioural counselling and prescription, it is expected that some
subjects that increased physical activity at six months might fall
back into their previous routine of inactivity. We report the final
results on the long term effectiveness of the PEPAF programme to
increase physical activity of primary care inactive patients
throughout 24 months after the beginning of the clinical trial.
Methods
The PEPAF project was a pragmatic cluster randomized
controlled clinical trial initiated in October 2003 at 11 primary
care centres in Spain [10]. The present study reports the long-term
effectiveness at six, 12- and 24-month follow-up measurements,
performed through March 2006.
Ethics Statement
The study complies with the guidelines of the Declaration of
Helsinki. The study was approved by the Clinical Research Ethics
Committees of the participating centres.
Participants and randomization
General practitioners were invited to participate through the
Spanish Preventive Services and Health Promotion Primary Care
Research Network. A detailed description of study setting and
participant recruitment is given elsewhere [10,14]. In short, a total of
70 family physicians as allocation units from 13 health centres were
randomized before patient recruitment, in a 1:1 ratio using
computer-generated random numbers provided by a central site,
the Primary Care Research Unit of Bizkaia. Randomisation of
physicians was stratified by centre. Two health centres (12 physicians)
dropped out before the start of the study due to technical difficulties,
and two practices refused to participate. In the end, 56 GPs from 11
primary health care centres initiated and completed the study, 29
allocated to the PEPAF group and 27 to the control group (Figure 1).
A sample of 16663 patients aged 20–80 from those scheduled
for an appointment during the recruitment period was selected by
research nurses using systematic sampling. Physicians, after
dealing with the reason for the consultation and guided by web-
based software, screened the physical activity level of 13042
selected patients. Due to non-attendance, severity of problems,
technical difficulties or lack of time, 3621 selected patients were
not assessed. Of those assessed, 2592 were identified as active,
while 10450 were eligible for the study (5473 and 4977 allocated to
the intervention and control groups, respectively) because they did
not meet the recommended aerobic physical activity levels
(moderate-intensity physical activity for $30 minutes 5 d/wk or
vigorous intensity activity for $20 minutes 3 d/wk) [3] (Figure 1).
The negative answer to the screening questions used by doctors to
identify active patients had a predictive value of 87.6% [14].
Computer screen shots guided physicians in reviewing exclusion
criteria: cardiovascular disease or other conditions that could
preclude exercising safely or could be exacerbated by exercise,
severe emotional distress, complicated pregnancies, and follow-up
difficulties. In the intervention and control groups, 2014 and 1635
eligible patients, respectively, met some exclusion criterion; 511 and
488, respectively, refused to participate when offered an informed
consent form; and 383 and 492, respectively, failed to attend the
baseline measurement session. Written informed consent was
obtained from all participants involved in the study. Of the 4927
patientswho completedthebaselinemeasurement,317 intervention
patients and 293 control patients were excluded because they
already met the minimum recommended levels of physical activity,
as confirmed in the baseline physical activity assessment performed
by research nurses. Finally, a total of 2248 intervention patients and
2069 control patients were included in the study (Figure 1).
Interventions
Figure S1 shows a graphical depiction and a detailed description
of the intervention. Assisted by web-based software, general
practitioners allocated to the PEPAF group provided brief advice
and educational materials focusing on the benefits of physical
activity and the risks of inactivity, and offered an additional 15-
minute appointment to prescribe an individualized physical
activity plan. Patients attending and not attending this appoint-
ment formed the prescription and advice subgroups, respectively.
In the case of the prescription subgroup (30% of the intervention
patients), after addressing potential barriers to and solutions to
enable change, physicians negotiated and prescribed a 3-month
physical activity plan aimed at gradual achievement of the
recommended physical activity levels (3), that resulted in a
standardized printed prescription with a self-monitoring log.
Physicians were suggested to review the physical activity plan
under an opportunistic strategy, resulting in the repetition of
32.1% of the initially prescribed plans. Quality of the recruitment
and intervention delivery processes was ensured by an intensive
training of general practitioners and the web-based software,
which obliged them to advance through several screens containing
standardized contents of the intervention, and registered the
process for each patient. Control group physicians assessed
patients’ physical activity and performed recruitment in a similar
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systematic intervention related to physical activity until the end of
the study, unless the reason for consultation or the patients’ health
problems were directly related to inactivity. Further description of
intervention content, its theoretical base, physicians’ training and
standardization procedures is given elsewhere [10,14]. The
protocol for this trial and the CONSORT checklist are available
as supporting information; see Protocol S1and Checklist S1.
Measurements and follow-up
The primary outcome measure was the change in physical
activity level estimated using the 7-day Physical Activity Recall (7-day
Figure 1. Flow chart of the PEPAF trial.
doi:10.1371/journal.pone.0018363.g001
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time spent on all kinds of leisure and occupational activities lasting
more than 10 accumulated minutes in the 7 days prior to the
interview. Minutes per week spent doing moderate and vigorous
physical activity and the proportion of participants who achieve the
minimum recommended physical activity levels are directly
calculated, while weekly activity dose in metabolic equivalents -
hour per week (MET*h/week) is estimated by multiplying the hours
devoted to activities of moderate, hard, and very hard intensity by
the corresponding METs: 4, 6, and 10 respectively. The 7-day PAR
validity has been accredited many times over the years, including
with Hispanic populations [16], and we evaluated it in a sample of
160 participants in our study, obtaining good reliability indexes
(intraclass correlation.0.6) and a correlation of 0.52 with an
objective measurement of activity dose (accelerometer).
Secondary outcome measures included maximal oxygen uptake
indirectly estimated by the YMCA cycle ergometer submaximal
exercise test [17] and health-related quality of life using the
Spanish version of the SF-36 questionnaire (version 1) [18]. We
consider as possible confounders baseline motivational stage of
change, assessed by a self-administered questionnaire [19]; social
class and educational level [20]; excessive alcohol consumption,
using the Spanish version of the AUDIT (risky drinker $8 points)
[21]; smoking status and demographic variables reported by
patients; and risk factors extracted from patients’ clinical records.
Trained nurses working in exercise laboratories who performed
baseline and follow-up measurements at 6, 12 and 24 months were
blinded to the allocation group of the participants. The quality of
measurements was assured by training of research nurses, a pilot
study, and double data entry into a central Oracle
TM database. A
telephone recall system was used to improve follow-up rates of
patient measurements. Quality control was performed by the
coordinating center (Primary Care Research Unit of Bizkaia) with
daily online supervision and feedback to nurses regarding the study
process and data entry, monthly progress reports, and regular
meetings every four months with the collaborating investigators
and research nurses.
Statistical and power analyses
To test overall effect of the intervention on an intention-to-treat
basis, we compared changes in outcome variables between the two
groups over the three follow-up measurements adjusted by baseline
values. Longitudinal generalized mixed models were used to take
into account the repeated measurements for each patient and also
the hierarchical structure of data, with patients nested in doctors
and health centers (SAS PROC MIXED and GLIMMIX ver. 9.2,
SAS Institute, Cary, NC, USA, 2009; SAS code available upon
request). These models were linear for changes in physical activity,
VO2max, and quality of life and logistic for achievement of the
minimum recommended physical activity levels. Time evolution
was considered in these models as a continuous variable, based on
linear, quadratic or logarithmic functions or as a categorical
variable, with several correlated measurements for each individual.
This last option was chosen since it is the less restrictive and
provided a better fit to our data. The PEPAF intervention, the time
of measurement and intervention-by-time interaction were included
as fixed effects in the models. Patients, doctors and centres were
included as random effects in the intercept and in the slope of the
different repeated measurements. These models were also adjusted
forbaselinevaluesoftheoutcome variables,the seasonofthe yearin
which the measurements were made, known determinants of
physical activity and physician characteristics. Different covariance
structures were used for the repeated observations on the same
patient, doctor and centre and restricted maximum likelihood ratio
tests were used to determine the best covariance structure for our
data. Likewise, to simplify the fixed effects structure, maximum
likelihood ratio tests were used following backward, forward and
stepwise strategies (significance criterion p,0.05).
We assessed the overall effect of the PEPAF programme by
testing the interaction between intervention and time of measure-
ment. When this intervention by time interaction was significant
(significance criteria p,0.05), planned contrasts were used to
determine whether changes in the PEPAF group between baseline
and each of the follow-up points were significantly different from
those observed in the control group (p,0.05). Finally, to describe
the effect of prescription in addition to advice, a predefined per-
protocol analysis was undertaken testing the ‘‘intervention group
by prescription’’ interaction (p,0.01).
In addition to previously mentioned random structure, random
effects on the PEPAF programme effect at centre level were
included to test whether the effect attributable to the intervention
varied across centres. Empirical Bayesian estimators were
calculated for each centre, followed by a sensitivity analysis to
evaluate changes after excluding centres whose populations
significantly differed from the overall average. Given the skewness
of the continuous outcome variables, sensitivity analysis was
repeated excluding patients considered as potential outliers,
namely, those beyond two standard deviations. No imputation
method was used to handle the missing data since longitudinal
mixed models based on maximum likelihood estimation used in
this article are more appropriate to deal with missing data [22]
than common imputation methods such as last observation carried
forward, complete case analysis or other possible forms of
imputation.
A post hoc power calculation based on longitudinal mixed-
effects models adjusted to the final sample size, actual data
variability, and clustering showed that the study has a power
greater than 95% to detect a minimal difference between
comparison groups of at least 2.25 METh/wk, 0.80 mL/kg/min
in VO2max and 5 points in SF-36 health-related quality of life
scores at any measurement point.
Results
A total of 3691 patients with at least one follow-up measurement
(85% of the 4317 recruited in the study) were included in the
longitudinalanalysis,1906fromthePEPAFgroupand1785fromthe
control group (Figure 1). Baseline characteristics of these participants
were balanced between both comparison groups with regard to the
primary and secondary outcomes, as well as to the majority of
sociodemographic and risk factors. The mean age was 50.6, 64.6%
were women, the average time devoted to moderate or vigorous
activities was 34.7 min/wk and the mean weekly activity level was 2.4
MET-h/wk. The control group had a higher proportion of patients
with dyslipidemia (p-value,0.001), and with low levels of education
(p-value=0.003), and a lower proportion in the ‘‘preparation’’ stage
of change (p-value,0.001). Additionally, baseline, 12 and 24-month
measurements were mostly made in autumn and winter, whereas the
majority of 6-month measurements were performed in spring and
summer. To control for these differences, subsequent analyses were
adjusted for these variables (see TABLE 1).
Both groups increased activity levels over the 24 month follow-
up period and the overall evolution was more favourable in the
intervention group (p,0.01) which showed higher increments in
physical activity at every follow-up point (TABLE 2, Figure 2). At
six months, compared with controls, those included in the PEPAF
group increased physical activity by 1.72 more MET hours/wk
(95% CI: 0.79 to 2.65), by 25 more min/wk devoted to moderate
Physical Activity Promotion by GPs
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Intervention Group Control Group
(N=1906) (N=1785)
Primary outcomes
Physical activity dose, METs * hour/week 2.46 ( 6.08) 2.37 ( 5.88)
Moderate and vigorous activity, minutes/week 35.94 (94.81) 33.45 (77.81)
Secondary outcomes
VO2max, ml/kg/min
a 24.30 (8.12) 24.63 (8.36)
Physical Component Summary
b 48.11 (8.26) 47.70 (8.39)
Mental Component Summary
b 45.87 (11.71) 46.76 (11.51)
Sociodemographic variables
Age, y 50.28 (14.66) 51.01 (14.80)
Female n( % ) 1259 (66.0) 1125 (63.0)
Work Situation n( % )
Works outside of home 956 (50.6) 882 (49.4)
Homemaker 469 (24.6) 424 (23.7)
Retired 283 (14.8) 325 (18.2)
Student 46 (2.4) 30 (1.7)
Unemployed 91 (4.8) 78 (4.4)
Other 52 (2.7) 46 (2.6)
Educational level n( % )
None 82 (4.3) 137 (7.7)
Elementary School 592 (31.1) 546 (30.6)
Middle or High School 894 (46.9) 812 (45.5)
University studies 388 (17.7) 290 (16.2)
Social Class
c n( % )
Manager large enterprise 126 (6.6) 130 (7.3)
Manager small enterprise 223 (11.7) 180 (10.1)
intermediate employee 551 (28.9) 541 (30.3)
Manual worker 1006 (51.9) 934 (52.3)
Risk factors n( % )
Diabetes 145 (7.6) 163 (9.1)
Hypertension 466 (24.4) 473 (26.5)
Dyslipidemia 381 (20.0) 429 (24.0)
Obese ($30 kg/m
2) 479 (25.1) 455 (25.5)
Current smoker 575 (30.2) 506 (28.3)
At-risk drinker n( % ) 104 (5.5) 83 (4.7)
Physical activity stage of change n( % )
Pre-contemplation 396 (20.8) 640 (35.8)
Contemplation 629 (33.0) 611 (34.23)
Preparation 617 (32.4) 319 (17.9)
Action 92 (4.8) 55 (3.1)
Maintenance 172 (9.0) 160 (9.0)
Values are means (standard deviation) unless otherwise stated.
aVariables derived from the cycle ergometer test at baseline: n=3089.
bSample size for Physical and Mental Component Summary: n=3652.
cSocial class classification based on occupation and work position (30): Class IV to V includes non-qualified and qualified manual workers; Class III includes the
administrative workforce, supervisors and freelance workers; Class II includes managers of enterprises with less than ten employees, professionals with first level
university degree, senior technicians, artists and sportsmen/women; Class I includes managers of public organizations or private enterprises with more than ten
employees, professionals with second and third level university degrees.
doi:10.1371/journal.pone.0018363.t001
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of the participants meeting the minimum physical activity
recommendations (95% CI: 2.1% to 8.8%). At the 12- and 24-
month follow-ups these differences, although still favourable to the
intervention group, were lower and not significant (p.0.05)
(TABLE 2, Figure 2). Age, sex and baseline stage of change, did
not modify the effect of the PEPAF intervention on the
longitudinal 24-month evolution of physical activity changes.
The secondary outcome analysis showed a small but significant
improvement in both groups in their VO2max levels and health-
related quality of life scores over time. However, no significant
differences were found between groups in the secondary outcomes
(p.0.05). (Table 2)
When analyzing the treatment actually received within the
programme, the trend to physical activity gain only appeared in
the prescription subgroups while the advice subgroup showed non
significant differences with the control group at every follow-up
point (PEPAF intervention by prescription subgroup interaction p-
value,0.007, see figure 2). At six months follow-up, those
receiving a prescription were 100% more active than controls,
with a difference of 4.17 METS hour/wk (95 CI% 2.80 to 5.54).
At 12 months this difference disappeared for the subgroup
receiving a single prescription but remained for those who
repeated the prescription (difference of 4.21 METS hour/wk;
95% CI 1.68 to 6.74). At 24 month follow-up the prescription
effect on activity dose was not significant (1.13 METS hour/w,
95% CI 21.74 to 4.01). However, in terms of the proportion of
participants meeting the minimum physical activity recommen-
dations, the effect of the repeat prescription remained significant
until the end of 24 months follow-up. For those having received a
repeat prescription this percentage surpassed that of the control
group by 14.83% at 6 months (95%CI 7.38% to 23.21%), by
11.49% (95%CI 3.08% to 20.51%) at 12 months, and by 10.17%
(95% CI 1.48% to 19.36%) at the 24 month follow-up (Figure 2).
Baseline characteristics of the patients who received a single
prescription and of those who received a repeat prescription were
balanced in most variables. However, among those patients who
received a single prescription there was a higher proportion of
Table 2. Longitudinal changes in primary outcomes: physical activity level.
Baseline adjusted change (95% CI)
Multivariate-adjusted
attributable difference
(95% CI)
Intervention -time of
measurement
interaction
Intervention Group Control Group
(n=1906) (n=1785) p-value
Primary Outcomes
Physical activity dose, MET-h/wk 0.004
6 months 7.07 (4.85–9.29) 5.32 (3.10–7.54) 1.72 (0.79–2.65)
12 months 7.76 (5.51–10.00) 7.29 (5.04–9.54) 0.49 (20.60–1.59)
24 months 9.09 (6.81–11.37) 8.29 (6.00–10.58) 0.62 (20.62–1.86)
Moderate and vigorous activity, min/wk 0.003
6 months 119.15 (86.50–151.80) 95.06 (62.36–127.76) 24.87 (11.33–38.40)
12 months 128.60 (95.73–161.47) 127.33 (94.40–160.26) 2.01 (212.56–16.59)
24 months 148.82 (115.41–182.23) 139.97 (106.49–173.46) 7.33 (29.75–24.42)
Proportion meeting physical activity recommendations, % 0.009
6 months 22.36 (17.56–28.03) 17.46 (13.47–22.34) 5.27 (2.08–8.79)
12 months 23.46 (18.38–29.45) 21.92 (17.05–27.70) 1.80 (21.97–5.85)
24 months 27.84 (21.09–35.78) 25.69 (19.27–33.37) 2.14 (21.81–6.32)
Secondary Outcomes
Estimated maximal oxygen uptake: VO2 mL/kg/min
a 0.368
6 months 1.62 (1.10–2.14) 1.41 (0.88–1.94) 0.24 (20.14–0.61)
12 months 1.10 (0.56–1.64) 1.21 (0.66–1..75) 20.11 (20.53–0.31)
24 months 1.06 (0.51–1.62) 0.86 (0.30–1.42) 0.18 (20.28–0.64)
Health Related Quality of Life: SF-36 Physical Component Summary
b 0.954
6 months 1.43 (0.64–2.23) 1.47 (0.67–2.27) 20.05 (20.48–0.38 )
12 months 1.20 (0.40–2.01) 1.30 (0.49–2.11) 20.10 (20.58–0.38 )
24 months 1.26 ( 0.45–2.08) 1.20 (0.39–2.02) 20.06 (20.44–0.55 )
Health Related Quality of Life: SF-36 Mental Component Summary
b 0.510
6 months 0.92 (20.34–2.18) 0.67(20.59–1.93) 0.43 (20.15–1.02)
12 months 1.18 (20.09–2.44) 1.30 (0.03–2.56) 0.06 (20.55–0.67)
24 months 1.64 (0.38–2.91) 1.85 (0.58–3.12) 0.00 (20.63–0.63)
Intention-to-Treat Analysis.
aSample size for the estimated maximal oxygen uptake n=3089 (Intervention group n=1598, control group n=1491).
bSample size for Physical and Mental Component Summaries: n=3652 (Intervention group n=1886, control group n=1766).
doi:10.1371/journal.pone.0018363.t002
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than those who received a repeat prescription.
While there was a significant variability in changes in physical
activity between the populations from the different collaborating
centres at every follow-up point (p-value ,0.001), the within-
centre effect attributable to the intervention did not vary across
centres (p-value .0.44). The seasonal effect was significant in all
the analyses (p-value ,0.0001). For the multivariate multilevel
model of the change in physical activity the estimated effect of the
season of the year in which measurements were made was the
results being higher by 3.65 METs*hour/week for those measured
in the spring, 1.89 for those from the summer, and 1.80 for the
autumn compared to those measured in the winter. Finally, the
sensitivity analysis excluding populations from centres that
significantly differed from the average showed no relevant changes
in either the direction or the magnitude of the observed effects.
When excluding patients considered as outliers, the overall
evolution was more favourable to the PEPAF programme because
not only was the intervention effect significant at 6 months, it also
remained significant until 12 month follow-up in METs hour/
week and minutes of moderate or vigorous activity (p,0.05).
Discussion
Physical activity increased significantly more for primary care
patients exposed to the PEPAF programme than for patients in the
control group. This improvement was shown during the initial six-
month follow-up, but the effect of the programme declined and
lost significance over 12 to 24 months. The mean effect size
achieved at six months may be considered of moderate clinical
relevance at an individual level, but a 5.3% higher percentage of
patients achieved the minimum recommended physical activity
level in the intervention group, this being relevant for public
health. After this six-month period, the effect attributable to the
intervention was lost. This trend of the effect of interventions
diminishing in the longer term after an initial increase has been
described in previous studies [7,11].
A loss of effectiveness in the very long term is expected as a
reflection of the lack of a continuous or ongoing intervention,
clinical reinforcement strategies and support in the community.
Indeed, comprehensive interventions combining informational,
behavioural and environmental approaches can be more effective
in the long term than interventions delivered only by physicians
Figure 2. Two years longitudinal change in physical activity by comparison groups and subgroups.
doi:10.1371/journal.pone.0018363.g002
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setting with 24 months of follow-up is mainly restricted to two high
quality studies that used the following intervention components in
addition to advice and information material: first, written
prescriptions of exercise by nurses or doctors linked to commu-
nity-based exercise facilitators or health educators who offer
support for goal setting, tailoring of physical activity plans, and
strategies for overcoming barriers; second, booster and reminder
strategies via telephone, internet, mail, personal meetings, follow-
up workshops, group sessions, printed materials or newsletters; and
third, feedback to the health professionals and updating of the
physical activity prescriptions [11,12,23]. However, evidence
remains scarce with respect to which components of such
interventions are effective and efficient in the long term, and this
warrants further investigation [7].
When analyzing the treatment actually received by participants
within the programme, a trend toward very long-term effectiveness
is associated with the repeat prescription subgroup. Those
participants who had repeated the individual physical activity
prescription showed clinically relevant differences at 12 months in
weekly activity levels with respect to the control group and even at
24 months in the proportion meeting the physical activity
recommendations. The interpretation of these on-treatment
analyses which lose the strength of randomization must be very
cautious. When attributing results to the physical activity
prescription, even after multivariate adjustment, residual con-
founding due to the self-selected nature of these subgroups may be
present. However, this analysis illustrates what might be expected
for patients who accept and repeat the prescription of a physical
activity plan. The long-term sustainability of the results in this
subgroup is consistent with the booster effect of interventions
which provide people with professional guidance in starting an
exercise programme and then provide ongoing support [6].
Long term increases in physical activity were associated with
improvements in cardiorespiratory fitness but these did not
translate into between-group differences, probably because most
patients increased physical activity through moderate intensity
activities. While the Activity Counseling Trial found significant
improvements in cardiorespiratory fitness in the subgroup of
women allocated two more intensive interventions [12], no
differences associated to physical activity prescription were
observed in our subgroup analysis. In any case, when interpreting
these results it should be taken into account that physical activity
per se has an influence on health, one that is not mediated by an
increase in fitness or by an improvement in the risk factor profile
[24]. No effect on quality of life was observed, which is consistent
with results in previous studies [25]. Adverse effects were not
considered because there is no evidence that physical activity
interventions cause harm [6].
Strengths and limitations
Comparing this study with others previously published, the
recruitment of a larger unselected sample of inactive patients, not
especially motivated to change, and the two-year follow-up give
our results greater generalizability and the power to enable results
to be analyzed in small subgroups. Overall, the patient
characteristics are representative of the common sociodemo-
graphic and clinical characteristics seen in primary care [14], and
the intervention was performed in routine primary care condi-
tions. A significant variability between physical activity changes
seen in the populations from the different centres, along with
homogeneity of the intervention effect across centres and their null
influence in the sensitivity analysis, supports the generalizability of
the results to other similar public primary care populations. The
longitudinal analyses used in this article have advantages over the
cross-sectional ones that we previously reported concerning the
preliminary results of the PEPAF clinical trial at 6-month time
point [10]. Longitudinal mixed models used in this article are
more appropriate to deal with missing data and standard errors for
intervention effects at each time point are calculated using
information from all the three measurement points and are
therefore more robust than those calculated in our previous paper.
The main limitation of the study is the self-reported measure-
ment of physical activity, which may be associated with recall and
social desirability bias. Although it would have been more valid to
use objective measures of physical activity, this would have been
impractical in such a large scale study with thousands of patients
and multiple measurements. Structured self-reported measure-
ments are an accepted method in population-based and clinical
studies, and this has been the method used in epidemiological
studies linking physical activity and health. In particular, the 7-day
Physical Activity Recall has been shown to correlate well with
objective measures in previous studies and in a sub-sample of our
study population [15,16,26,27]. Another weakness is the lack of
blinding of participants. Outcome assessment was blinded to
minimize to some extent this bias. Specifically, intervention and
control subjects performed the same interview with blinded nurses,
and accordingly measurement error is expected to be non-
differential. Randomization of physicians before patient recruit-
ment prevented concealment in the patient enrolment process. To
minimize a potential recruitment bias, patients to be assessed for
inclusion in the study were randomly selected. Despite this
measure, it was found that there were a higher proportion of
‘‘prepared’’ patients in the PEPAF group; accordingly, baseline
stage of change was considered as a confounder and all analysis
were adjusted for this. Since the proportions of people in action
and maintenance were similar and physician counselling has been
shown to have an immediate effect on patients’ readiness to
change [28], an explanation, other than recruitment bias, would
be the effect of medical advice received by this group immediately
before the baseline measurement, causing a transfer of ‘‘pre-
contemplators’’ toward the self-reported ‘‘preparation’’ stage of
change.
Another factor contributing to the reduction in the measured
effectiveness of the intervention over the longer term in our study
is the significant increase in physical activity in the control group, a
phenomenon that has also been found in other studies [6,7,11,12].
This might be due to an effect of the repeated physical activity
assessment and research procedures implemented by doctors; a
seasonal effect resulting from baseline, 12 and 24-month
measurements mostly having been made in autumn and winter
and 6-month follow-up measurements during spring and summer;
and especially, to an effect of the repeated measurement of
physical activity, fitness and other examinations and question-
naires, which involved approximately 45 minutes with a research
nurse and might have acted as an intervention in itself [29,30].
This intensive measurement may have given patients an increased
awareness of their own level of physical activity and fitness status,
resulting in behavioural change. It is also possible that there was
contamination of control physicians; randomization by centre
would have been more effective to control this. However, it was
also important to control heterogeneity and variability from centre
to centre; and for this reason it was decided to randomize doctors
stratified within centres. As there was some within-centre
correlation, this option can be judged to have increased the
power of the study and experts have commented that concern
about contamination is frequently overemphasized [31].
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General practitioners can enable inactive patients to increase
their levels of physical activity, but without reinforcement
strategies the results tend to decline over time.
Repeat prescription of a physical activity plan can produce
sustained increases in physical activity with great health impact.
According to the literature, comprehensive approaches involving
repeated interventions that include behaviour change techniques
and booster programs might enhance the long-term effectiveness
of advice given by physicians and other health care professionals
[7]. Yet, the main challenge remains how to integrate these kinds
of interventions into routine primary care in a feasible and
sustainable way. Future studies should address the modelling and
evaluation of these new and complex interventions [32,33].
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